Study shows costly weight loss drug may also cut risks of heart attacks |
|
The nation’s obesity epidemic is growing. Nearly 42 percent of all American adults are considered obese. Now, new findings about the FDA-approved weight-loss drug Wegovy may lead to even more demand for a medication that can be both life-changing and expensive. William Brangham reports.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG Find more from PBS NewsHour at https://www.pbs.org/newshour Subscribe to our YouTube channel: https://bit.ly/2HfsCD6 Follow us: TikTok: https://www.tiktok.com/@pbsnews Twitter: http://www.twitter.com/newshour Instagram: http://www.instagram.com/newshour Facebook: http://www.pbs.org/newshour Subscribe: PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts Newsletters: https://www.pbs.org/newshour/subscribe |